The first phase of the project will take approximately six months. It will involve testing each of the devices and building the living labs at the 5G Innovation Centre, University of Surrey and Surrey Centre for Clinical Research. The collection of Expressions of Interest of participants and volunteers will begin in October 2016 and will be ongoing.  

During phase two staff, participants and volunteers will be trained in how to use a combination of devices. The ‘technical pilot’ in a small number of homes across Surrey and North East Hampshire will begin.   

This will be followed by a wider roll out of the study across 350 homes. In total, 1400 people will be involved in the research. The devices will be placed in the homes of 350 people with dementia. The impact of our research will be benchmarked against data from a control group of 350 people with dementia who will not have the devices installed in their homes. A randomised tool will be used to select who will be included in each group.  

The final phase, which will take place during early 2018, will involve evaluating the work and reporting on the findings and conclusions. This will be overseen by a strong leadership team with a track record of successful project delivery and operational, clinical and information governance. Proposals of how TIHM for dementia can be applied more widely beyond the project to benefit other long-term physical and mental health conditions will also be published to support wider innovations in healthcare.